Frontlight ResearchEarly access
Trial site
University of California San Diego (UCSD)
- 5running trials
- 6closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Lung cancer2 trials
- Atopic dermatitis (eczema)1 trial
- Epilepsy1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Heart failure1 trial
- Lupus (SLE)1 trial
- Metastatic breast cancer1 trial
- Parkinson disease1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 34 trials
- Phase 13 trials
- Phase 23 trials
- Status
- Completed4 trials
- Active, not recruiting3 trials
- Recruiting2 trials
- Suspended1 trial
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Ionis Pharmaceuticals, Inc.2 trials
- Applied Therapeutics, Inc.1 trial
- Bellicum Pharmaceuticals1 trial
- Daiichi Sankyo1 trial
- Gilead Sciences1 trial
- and 6 more
Running trials
Active, not recruiting
First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer
Active, not recruiting
Study With Various Immunotherapy Treatments in Participants With Lung Cancer
Recruiting
Recruiting
Active, not recruiting
Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atopic dermatitis (eczema)1 recruiting
- Parkinson disease1 recruiting
Closed trials
Withdrawn
Completed
Completed
Completed
A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia
Completed
Terminated
Site data: ClinicalTrials.govUpdated 17 Nov 2026